Christopher McQuinn
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
- CAR-T cell therapy research
-
- Immune cells in cancer
- Phagocytosis and Immune Regulation
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
- Co-authors
- Gregory B. Lesinski (3 shared papers)Thomas A. Mace (3 shared papers)Tanios Bekaii‐Saab (2 shared papers)Michael C. Ostrowski (1 shared paper)Teresa A. Zimmers (1 shared paper)Mark Bloomston (1 shared paper)Shannon Loftus (1 shared paper)Emily Nordquist (1 shared paper)
- Journals
- Cancer Immunology Immunotherapy (1 paper)Journal of Vascular Surgery (1 paper)Cancer Research (1 paper)Gut (1 paper)PubMed (1 paper)
- Partner nations
- United States
In The Last Decade
Christopher McQuinn
5 papers receiving 434 citations
Christopher McQuinn's Hit Papers
Peers
Comparison fields: 5 of 55
- Oncology 337
- Immunology 187
- Cancer Research 62
- Biotechnology 19
- Pathology and Forensic Medicine 37
Countries citing papers authored by Christopher McQuinn
This map shows the geographic impact of Christopher McQuinn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher McQuinn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher McQuinn more than expected).
Fields of papers citing papers by Christopher McQuinn
This network shows the impact of papers produced by Christopher McQuinn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher McQuinn. The network helps show where Christopher McQuinn may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher McQuinn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer Hit paper breakdown → | 2016 | 401 |
| 2 | 2021 | 23 | |
| 3 | Glomerulosclerosis, arteriosclerosis, and vascular graft stenosis: treatment with oral heparinoids. | 1997 | 13 |
| 4 | 2020 | 1 | |
| 5 | 2019 | 1 | |
| 6 | 2017 | 0 |
About Christopher McQuinn
Christopher McQuinn is a scholar working on Surgery, Oncology, Immunology, Molecular Biology and Pathology and Forensic Medicine, having authored 6 papers that have together received 439 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (3 papers), Pancreatic and Hepatic Oncology Research (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (1 paper), Colorectal Cancer Treatments and Studies (1 paper), Phagocytosis and Immune Regulation (1 paper), Genetic factors in colorectal cancer (1 paper), Bone and Dental Protein Studies (1 paper) and Tissue Engineering and Regenerative Medicine (1 paper). The work is most often cited by research in Oncology (337 citations), Immunology (187 citations), Cancer Research (62 citations), Biotechnology (19 citations) and Pathology and Forensic Medicine (37 citations). Christopher McQuinn has collaborated with scholars based in United States. Frequent co-authors include Gregory B. Lesinski, Thomas A. Mace, Tanios Bekaii‐Saab, Michael C. Ostrowski, Teresa A. Zimmers, Mark Bloomston, Shannon Loftus, Emily Nordquist, Reena Shakya and Zobeida Cruz‐Monserrate. Their work appears in journals such as Cancer Immunology Immunotherapy, Journal of Vascular Surgery, Cancer Research, Gut and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.